Search

Despite major advances in investigating haematological abnormalities, the blood film can still be crucial in diagnosis and patient management. The first major role is the validation of an abnormal blood count and, when it is found to be invalid, finding an explanation for factitious results. Factitiously low platelet counts and factitiously high MCVs are well recognized examples.

When the count is found to be valid, an explanation might be revealed. A blood film may indicate a likely diagnosis within minutes; this can be of vital importance as in acute promyelocytic leukaemia, thrombotic thrombocytopenic purpura, Burkitt lymphoma and certain infections. Sometimes the blood film suggests an uncommon or rare condition the diagnosis of which is important but would otherwise be delayed or elusive.

The effects of long COVID on coagulopathy

The new Certificate of Expert Practice in Laboratory IT and Clinical Informatics

This talk is designed to be a “get ready” session where we introduce the ePortfolio system and present a high-level overview of the extensive features that Onefile offers, whilst simultaneously streamlining administration and reducing repetition. This will form an essential training and familiarisation opportunity for both trainers and trainees.

Digital tools are revolutionising the way researchers, clinicians, and educators manage and showcase their qualifications and career milestones. The IBMS are excited to be part of that revolution by launching version 5 of our Registration Training Portfolio on Onefile, a leading ePortfolio platform. The transition to a digital-only solution hosted by Onefile will redefine how students, apprentices and laboratory-based staff complete this integral part of their journey to HCPC registration as biomedical scientists.

Onefile offers a multifaceted approach to collating, managing and auditing a portfolio of evidence; simultaneously providing a robust and efficient process for training officers and managers to support and supervise the journey of their trainees from enrolment, portfolio completion and finally to successful verification.

Rather than providing a demonstration of Onefile per se, this talk will allow delegates to see how the platform can be easily embedded into their existing training structure. We will suggest a delivery workflow so users can maximise the features and benefits of Onefile and we will outline a roadmap of user training, plus other support to facilitate the transition to Onefile in their laboratories and / or universities over the coming months.

This talk will be informative for anyone who is involved in or responsible for pre-registration laboratory training, in particular portfolio candidates, training officers, laboratory managers and university placement tutors.

Additional talks focusing on specific elements of Onefile are scheduled for the free seminar programme on Thursday. These talks will specifically consider Onefile from the perspective of trainees and trainers (11.00am, Hall: 4), and training officers/laboratory managers/portfolio verifiers (2.30pm, Hall: 4).

A robust approach to Registration Training Portfolio verification is crucial to maintaining the high standards of confidence in the reputation of HCPC-registered biomedical scientists. The transition to a digital-only Registration Training Portfolio using the ePortfolio platform Onefile will provide a more streamlined approach to portfolio verification allowing verifiers to focus on what matters most… the assessment of a trainee’s competence.

This talk (the last of three) will demonstrate how verifiers can use Onefile to verify the evidence provided by the trainee and approved by their training officer or manager, using a number of tools to track evidence against the HCPC Standards of Proficiency. Onefile’s ePortfolio allows verifiers to gain a holistic view of the trainee’s understanding, enabling verifiers to scaffold the discussion during the verification visit and laboratory tour. We will see how Onefile provides a comprehensive system to arrange the verification visit (either virtually or in person), complete the verification report, and manage the final sign-off of the verified portfolio. Onefile’s inbuilt audit trail minimises the administration associated with portfolio verification, and we will show how this can be used to help improve the quality of education and training in the workplace.

We suggest that this talk will be most informative to post-registration staff involved in overseeing training, such as training officers/managers and verifiers.

Additional talks focusing on other elements of Onefile are scheduled for the lunchtime programme on Wednesday (Hall: 11) and the morning subsidiary programme on Thursday (Hall: 4).

The transition to a digital-only Registration Training Portfolio using the ePortfolio platform Onefile, will redefine students, apprentices and laboratory-based staff complete this integral part of their journey to HCPC registration as biomedical scientists and represents an up-to-date approach to education and training.

This talk (the second of three) will demonstrate how Onefile can be used by trainees and trainers to provide an enhanced training experience over traditional paper-based portfolios. We will delve into the use of Onefile to create and upload evidence; set tasks and monitor deadlines; organise meetings and track progress against the HCPC Standards of Proficiency; identify training gaps and create workflows to sign-off each module in the portfolio. We will see how Onefile provides a comprehensive audit trail with minimal user input and how this can be used to help ensure quality education and training in the workplace.

We suggest that this talk will be informative to trainees undertaking version 5.0 of the Registration Training Portfolio, as well as delegates in roles that support trainees, such as training officers/managers and university placement tutors.

Additional talks focusing on other elements of Onefile are scheduled for the lunchtime programme on Wednesday (Hall: 11) and the afternoon subsidiary programme on Thursday (Hall: 4).

This presentation will provide a detailed review of the updated HCPC Standards of Proficiency (SoPs) for biomedical scientists. The standards were updated in 2022 and have been implemented from 1st September 2023.

The updated SoPs for biomedical scientists align to the contents of the IBMS Registration Training Portfolio which must be successfully completed to register as a biomedical scientist. The updated Registration Training Portfolio (Version 5.0) has been mapped to the updated HCPC SoPs and will be issued to all applicants after 1st September 2023.

Both colleagues undertaking training to become registered biomedical scientists and those who are already registrants with the HCPC will be required to meet the new HCPC SoPs.

The language in the updated SoPs is much more focussed on demonstrating the standards rather than having knowledge of them, which will require a shift in how we evidence that the standards are met in practice.

This session will discuss the Version 5.0 portfolio structure, examples of evidence types that can be used to demonstrate the updated standards and will also introduce the mandatory pieces of evidence that are now part of each module of the Version 5.0 IBMS Registration Training Portfolio. The rationale for the changes to the portfolio and the support available from the Institute during this transition period will also be explained.

This talk will be informative for anyone who is involved in or responsible for pre-registration laboratory training, in particular registration training portfolio candidates, training officers, laboratory managers and university placement tutors.

Several sessions will be presented by the IBMS Head of Digital Education (Jim Taylor) throughout Congress, explaining how the Version 5.0 digital portfolio on Onefile will provide and enhanced training experience over traditional paper-based portfolios.

The new molecular pathology Specialist Portfolio

Thrombophilia is defined as hereditary and/or acquired conditions associated with an increased predisposition to thrombosis. The previous British Society for Haematology guideline on thrombophilia testing (2012) focused only heritable thrombophilia testing. The updated guideline published in 2022 (1) has a widened scope to include both heritable and acquired thrombophilia especially antiphospholipid antibodies, paroxysmal nocturnal haemoglobinuria, myeloproliferative neoplasm (MPN) and the presence of a JAK2 mutation in the absence of an MPN phenotype. Disorders such as cancer, inflammatory conditions and obesity are associated with thrombosis through multiple mechanisms, but these are not included in the guideline which focuses only the factors identified from laboratory testing.

The key principle in the guideline is that when clinical utility of testing is not clear, thrombophilia testing is not mandatory, and testing should be done only if the result will alter the management of the patient. These guidelines emphasise the importance of identifying antiphospholipid syndrome and JAK2 +/- MPN phenotype because they have a significant impact on management. The guidelines confirm the limited utility of testing for hereditary thrombophilia testing in venous thromboembolism, arterial thrombosis and recurrent pregnancy loss.

1. Arachchillage, DJ, Mackillop, L, Chandratheva, A, Motawani, J, MacCallum, P, Laffan, M. Thrombophilia testing: A British Society for Haematology guideline. Br J Haematol. 2022; 198: 443– 458. https://doi.org/10.1111/bjh.18239

Join your network workforce leads/practice educators for a solution focused discussion around workforce challenges. Find out about current education and development opportunities with specific emphasis on support workers, advanced clinical practice and leadership. We welcome your participation in helping to shape the future of your pathology workforce.

You are invited by the speakers to complete this online form before the presentation